早期血浆基质金属蛋白酶谱:儿童急性呼吸窘迫综合征的新通路
研究在2008至2017年间五家医院235例儿童ARDS患者中,检测第1天血浆MMP通路蛋白,用潜在类别分析识别不同MMP谱,并分析其与炎症标志物、内皮损伤标志物、氧合指标、并发症和死亡的关系。在地理上不同的推导队列和验证队列中,约三分之一患者表现为MMP-1、-2、-3、-7、-8及TIMP-1、-2升高、活性和总MMP-9降低的MMP谱,该谱与第1天多种炎症标志物、内皮损伤标志物和氧合障碍相关,且独立于P/F比和其他混杂因素,死亡或严重并发症的比值比增加四倍(95%CI 2.1-7.6,P<0.001)。联合P/F比和MMP谱的logistic回归模型对死亡或严重并发症的预测优于单用P/F比(AUC 0.75,95%CI 0.68-0.82 vs AUC 0.66,95%CI 0.58-0.73,P=0.009)。结论认为儿童ARDS存在特定血浆MMP谱,与炎症、内皮损伤、并发症和死亡相关,MMP可能参与儿童ARDS的病理生物学。
要点
- 儿童ARDS第1天血浆MMP谱中,约三分之一患者表现为MMP-1、-2、-3、-7、-8及TIMP-1、-2升高、活性和总MMP-9降低。
- 该MMP谱与第1天多种炎症标志物、内皮损伤标志物和氧合障碍相关,且独立于P/F比和其他混杂因素。
- 该MMP谱与死亡或严重并发症风险增加四倍相关(95%CI 2.1-7.6,P<0.001)。
- 联合P/F比和MMP谱预测死亡或严重并发症的AUC为0.75(95%CI 0.68-0.82),优于单用P/F比的AUC 0.66(95%CI 0.58-0.73),P=0.009。
适用人群与场景
- 2008至2017年间五家医院收治的235例儿童ARDS患者,于ARDS第1天采集血浆。
研究设计与关键结果
- 研究类型为在五家医院开展的队列研究,纳入235例儿童ARDS患者,于ARDS第1天采集血浆检测MMP通路蛋白。
- 采用潜在类别分析识别MMP谱,在地理上不同的推导队列和验证队列中,约三分之一患者表现为MMP-1、-2、-3、-7、-8及TIMP-1、-2升高、活性和总MMP-9降低的MMP谱。
- 该MMP谱与第1天多种炎症标志物(IL-1RA、IL-6、IL-8、IL-10、IL-18、巨噬细胞炎症蛋白-1α和-1β、肿瘤坏死因子-α和-R2)、内皮损伤标志物(血管生成素-2、血管性血友病因子、可溶性血栓调节蛋白)和氧合障碍(PaO2/FiO2比、氧合指数)相关。
- 该MMP谱独立于P/F比和其他混杂因素,与死亡或严重并发症风险增加四倍相关(95%CI 2.1-7.6,P<0.001)。
- 联合P/F比和MMP谱的logistic回归模型预测死亡或严重并发症的AUC为0.75(95%CI 0.68-0.82),优于单用P/F比的AUC 0.66(95%CI 0.58-0.73),P=0.009。
证据类型、等级与局限
- 证据类型为队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为MMP可能参与儿童ARDS的病理生物学;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: MMPs (Matrix metalloproteinases) and their endogenous tissue inhibitors may contribute to lung injury through extracellular matrix degradation and modulation of inflammation and fibrosis.
OBJECTIVES: To test for an association between MMP pathway proteins and inflammation, endothelial dysfunction, and clinical outcomes.
METHODS: We measured MMPs in plasma collected on acute respiratory distress syndrome (ARDS) Day 1 from 235 children at five hospitals between 2008 and 2017. We used latent class analysis to identify patients with distinct MMP profiles and then associated those profiles with markers of inflammation (IL-1RA, -6, -8, -10, and -18; macrophage inflammatory protein-1α and -1β; tumor necrosis factor-α and -R2), endothelial injury (angiopoietin-2, von Willebrand factor, soluble thrombomodulin), impaired oxygenation (PaO2/FiO2 [P/F] ratio, oxygenation index), morbidity, and mortality.
MEASUREMENTS AND MAIN RESULTS: In geographically distinct derivation and validation cohorts, approximately one-third of patients demonstrated an MMP profile characterized by elevated MMP-1, -2, -3, -7, and -8 and tissue inhibitor of metalloproteinase-1 and -2; and depressed active and total MMP-9. This MMP profile was associated with multiple markers of inflammation, endothelial injury, and impaired oxygenation on Day 1 of ARDS, and conferred fourfold increased odds of mortality or severe morbidity independent of the P/F ratio and other confounders (95% confidence interval, 2.1-7.6; P < 0.001). Logistic regression using both the P/F ratio and MMP profiles was superior to the P/F ratio alone in prognosticating mortality or severe morbidity (area under the receiver operating characteristic curve, 0.75; 95% confidence interval, 0.68-0.82 vs. area under the receiver operating characteristic curve, 0.66; 95% confidence interval, 0.58-0.73; P = 0.009).
CONCLUSIONS: Pediatric patients with ARDS have specific plasma MMP profiles associated with inflammation, endothelial injury, morbidity, and mortality. MMPs may play a role in the pathobiology of children with ARDS.
参考来源
- Zinter MS, Delucchi KL, Kong MY, et al. Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2019. PMID: 30114376. doi:10.1164/rccm.201804-0678OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。